The Use of Liposomal Bupivacaine in TAP Blocks for Women Undergoing Cesarean Section

• Status: Withdrawn
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Female

Summary

This present investigation aims to determine whether a transversus abdominous plane(TAP) block, utilizing liposomal bupivacaine (Exparel), at the conclusion of a cesarean section decreases post-operative pain. The hypothesis is that performance of the TAP block with liposomal bupivacaine will decrease post-operative narcotic use.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Milton S. Hershey Medical Center
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• Patients >18 years of age

• Scheduled cesarean section with or without bilateral tubal ligation

• Planned performance of a Pfannenstiel incision

• Patients are schedule to have a cesarean section with a member of the Women's Health or Maternal and Fetal Medicine Departments at Penn State University Hershey S. Medical Center

Exclusion Criteria:

• History of opioid use

• History of chronic pain syndrome

• Use of general anesthesia during cesarean delivery

• Postoperative SICU admission

• Postpartum hemorrhage (defined as an Estimated Blood Loss of greater then 1,000mL upon completion of the cesarean section)